TAGRISSO 40 MG 30 F.C.TABS
سعر TAGRISSO 40 MG 30 F.C.TABS
103524.00 جنية
الشركة المنتجة لـ TAGRISSO 40 MG 30 F.C.TABS
ASTRA ZENECA > ASTRAZENECA SCIENTIFIC OFFICE
المادة الفعالة TAGRISSO 40 MG 30 F.C.TABS
OSIMERTINIB
معلومات عن TAGRISSO 40 MG 30 F.C.TABS
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug for mutated EGFR cancers.
Osimertinib is used to treat locally advanced or metastatic non-small-cell lung cancer (NSCLC) when the cancer has the specific T790M mutation in the gene coding for epidermal growth factor receptor.
